ArticleAdvances in therapy2026

Retifanlimab Versus Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma: A Matching-Adjusted Indirect Comparison Analysis.

Camilla Porta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.